Thrilled With Positive Results of Anti-Covid Pill, Cannot Speculate on India Launch: Pfizer

Pfizer plans to submit Paxlovid data for emergency use approval in the US as soon as possible, followed by other markets. It, however, refused to speculate on regulatory timelines.

Source: Top India News- News18.com